Abstract
There is currently interest in the potential use of selective inhibitors of cyclic nucleotide phosphodiesterases (PDE) in the treatment of asthma. In this study we examined the effects of three selective PDE inhibitors, milrinone (PDE III), rolipram (PDE IV) and zaprinast (PDE V), on the broncoconstriction produced by antigen and histamine, the airway hyperreactivity and microvascular leakage after aerosol exposure to platelet-activating factor (PAF) and antigen, and the antigen-induced eosinophil infiltration in guinea-pig lung. Inhaled rolipram (0.01–10 mg ml−1) inhibited dose dependently the bronchospasm produced by aerosol antigen (5 mg ml−1) an anaesthetised, ventilated guinea-pigs. Rolipram (10 mg ml−1) produced maximal inhibition of antigen-induced bronchoconstriction but only partial inhibition of the response to aerosol histamine (1 mg ml−1). Milrinone and zaprinast (each 10 mg ml−1) showed weak, or no, inhibitory effects against bronchoconstriction produced by aerosol antigen or histamine. Pretreatment with rolipram (10 mg kg−1, i.p.) prevented airway hyperreactivity to histamine which develops 24 h after exposure of conscious guinea-pigs to aerosol PAF (500 μg ml−1) or antigen (5 mg ml−1). The pulmonary eosinophil infiltration obtained with 24 h of antigen-exposure was inhibited by rolipram. In contrast, milrinone and zaprinast (each 10 mg kg−1, i.p.) failed to reduce either the airway hyperreactivity of the eosinophil accumulation in these animals. Rolipram (1–10 mg ml−1) reduced the extravasation of Evans blue after aerosol PAF (500 μg ml−1) at all airway levels while a lower dose (0.1 mg ml−1) was only effective at intrapulmonary airways. Rolipram (0.01–1 mg ml−1) markedly reduced airway extravasation produced by inhaled antigen (5 mg ml−1). Zaprinast (1–10 mg ml−1) was also effective against airway microvascular leakage produced by aerosol PAF or antigen while milrinone (10 mg ml−1) had no antiexudative effect. These data support previous suggestions that pharmacological inhibition of PDE IV results in anti-spasmogenic and anti-inflammatory effects in the airways and may be useful in the treatment of asthma.
Similar content being viewed by others
References
Banner KH, Page CP (1995) Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs. Br J Pharmacol 114:93–98
Beavo JA, Reifsnyder DH (1990) Primary sequence of cyclic nucleotide phosphodiesterase isoenzymes and the design of selective inhibitors. Trends Pharmacol Sci 11:150–155
Boer J de, Philpott AJ, Amsterdam RGM van, Shahid M, Zaagsma J, Nicholson CD (1992) Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors. Br J Pharmacol 106:1028–1034
Cortijo J, Bou J, Beleta J, Cardelús I, Llenas J, Morcillo E, Gristwood RW (1993) Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus. Br J Pharmacol 108:562–568
Cortijo J, Ortiz JL, Vallés JM, Morcillo EJ (1994) Inhaled rolipram and zaprinast inhibit airway microvascular leakage produced by inhaled platelet-activating factor in the guinea-pig (abstract). Br J Pharmacol 112:592P
Dent G, Magnussen H, Rabe KF (1994) Cyclic nucleotide phosphodiesterases in the human lung. Lung 172:129–146
Evans TW, Rogers DF Aursudkij B, Chung KF, Barnes PJ (1988) Inflammatory mediators involved in antigen-induced airway microvascular leakage in guinea-pigs. Am Rev Respir Dis 138:395–399
Farmer SG, Wilkins DE, Meeker SA, Seeds EAM, Page CP (1992) Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophilia in guinea-pigs. Br J Pharmacol 107:653–659
Giembycz MA (1992) Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma? Biochem Pharmacol 43:2041–2051
Giembycz MA, Dent G (1992) Prospects for selective nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma. Clin Exp Allergy 22:337–344
Havill AM, Van Valen RG, Handley DA (1990) Prevention of nonspecific airway hyperreactivity after allergen challenge in guinea-pigs by the PAF receptor antagonist SDZ 64–412. Br J Pharmacol 99:396–400
Howell RE, Sickels BD, Woeppel SL (1993) Pulmonary antiallergic and bronchodilator effects of isoenzyme-selective phosphodiesterase inhibitors in guinea-pigs. J Pharmacol Exp Ther 264:609–615
Hui KP, Lötvall J, Chung KF, Barnes PJ (1991) Attenuation of inhaled allergen-induced airway microvascular leakage and airflow obstruction in guinea-pigs by a 5-lipoxygenase inhibitor (A-63162). Am Rev Respir Dis 143:1015–1019
Lagenta V, Moodley I, Perrin S, Mottin G, Junien JL (1994) Effects of isoenzyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea-pig lung. Eur J Pharmacol 255:253–256
Lagente V, Pruniaux MP, Junien JL, Moodley I (1995) Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors. Am J Respir Crit Care Med 151:1720–1724
Nicholson CD, Shahid M (1994) Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Their potential utility in the therapy of asthma. Pulm Pharmacol 7:1–17
Ortiz JL, Cortijo J, Vallés JM, Bou J, Morcillo EJ (1992) Rolipram inhibits PFA-induced airway microvascular leakage in guinea-pigs: a comparison with milrinone and theophylline. Fundam Clin Pharmacol 6:247–249
Ortiz JL, Cortijo J, Vallés JM, Bou J, Morcillo EJ (1993) Rolipram inhibits airway microvascular leakage induced by platelet-activating factor, histamine and bradykinin in guinea-pig. J Pharm Pharmacol 45:1090–1092
Raeburn D, Lewis S (1991) Rolipram inhibits PAF-induced bronchial hyperreactivity (BHR) in the guinea-pig in vivo: A comparison with theophylline and salbutamol (abstract). Eur Respir J 4 (suppl 14): 307s
Raeburn D, Karlsson JA (1992) Comparison of the effects of isoenzyme-selective phosphodiesterase inhibitors and theophylline on PAF-induced plasma leak in the guinea-pig airways in vivo (abstract). Am Rev Respir Dis 145:A612
Raeburn D, Karlsson JA (1993) Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo. J Pharmacol Exp Ther 267:1147–1152
Raeburn D, Woodman V, Buckley G, Karlsson JA (1991) Inhibition of PAF-induced microvascular leakage in the guinea-pig lung in vivo: The effect of rolipram and theophylline (abstract). Eur Resp J 4 (suppl 14):590s
Raeburn D, Underwood SL, Lewis SA, Woodman VR, Battram CH, Tomkinson A, Sharma S, Jordan R, Souness JE, Webber SE, Karlsson JA (1994) Anti-inflammatory and bronchodilator properties of RP73401, a novel and selective phosphodiesterase type IV inhibitor. Br J Pharmacol 113:1423–1431
Sakamoto T, Barnes TJ, Chung KF (1993) Effect of β2-adrenoceptor agonists against platelet-activating factor induced airway microvascular leakage and bronchoconstriction in the guinea pig. Agents Actions 40:50–56
Schudt C, Winder S, Eltze M, Kilian U, Beume R (1991) Zardaverine: a cyclic AMP specific PDE III/IV inhibitor. Agents Actions 34 (suppl):379–402
Sturm RJ, Osborne MC, Heaslip RJ (1990) The effect of phosphodiesterase inhibitors on pulmonary inflammatory cell influx in ovalbumin sensitized guinea-pigs (abstract). J Cell Biochem, 14C (Suppl.):337
Suttorp N, Weber U, Welsh T, Schudt C (1993) Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest 91:1421–1428
Tokuyama K, Lötvall JO, Barnes PJ, Chung KF (1991) Mechanism of airway narrowing caused by inhaled platelet-activating factor. Am Rev Respir Dis 143:1345–1349
Torphy TJ, Undem BJ (1991) Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 46:512–523
Underwood SL, Lewis SA, Raeburn D (1992) RP58802B, a long-acting β2-adrenoceptor agonist: Assessment of antiasthma activity in the guinea-pig in vivo. Pulm Pharmacol 5:203–212
Underwood DC, Osborn RR, Novak LB, Mattews JK, Newsholme SJ, Undem BJ, Hand JM, Torphy TJ (1993) Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea-pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J Pharmacol Exp Ther 266:306–313
Underwood DC, Kotzer CJ, Bochnowicz S, Osborn RR, Luttmann MA, Hay DWP, Torphy TJ (1994) Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea-pigs. J Pharmacol Exp Ther 270:250–259
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ortiz, J.L., Vallés, J.M., Martí-Cabrera, M. et al. Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs. Naunyn-Schmiedeberg's Arch Pharmacol 353, 200–206 (1996). https://doi.org/10.1007/BF00168758
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168758